Literature DB >> 11120605

Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells.

A S Vercoutter-Edouart1, X Czeszak, M Crépin, J Lemoine, B Boilly, X Le Bourhis, J P Peyrat, H Hondermarck.   

Abstract

Fibroblast growth factor-2 (FGF-2) is a potent regulator of breast cancer cell growth through stimulation of tyrosine kinase receptors and activation of the mitogen-activated protein kinase cascade. In the present study, we have investigated changes in protein synthesis induced by FGF-2 stimulation of the prototypic human breast cancer cell line MCF-7. Using high-resolution two-dimensional electrophoresis of (35)S amino acid metabolically labeled proteins and computerized analysis of 2D autoradiograms, we found that four proteins were up-regulated within the first 12 h of FGF-2 stimulation. Mass spectrometry analysis (MALDI-TOF and MS-MS) of tryptic fragments and database searches allowed the identification of these FGF-2-regulated proteins as the heat shock proteins HSP90 and HSP70, the proliferating cell nuclear antigen (PCNA), and the transcriptionaly controlled tumor protein (TCTP). We then analyzed the distribution of these proteins in various cancerous and normal breast epithelial cells. Interestingly, the four FGF-2-regulated proteins were found to be constitutively up-regulated in ras-transfected MCF-7 cells, indicating their relevance to the up-regulation of cellular proliferation. Moreover, HSP90 and PCNA were found at higher levels in cancerous cells than in normal cells. The role of HSP90 was further investigated using the specific inhibitor geldanamycin. We showed that the functionality of HSP90 is strictly required in order to obtain FGF-2 mitogenic stimulation in MCF-7 cells, indicating the crucial role played by this molecular chaperone in the control of breast cancer cell growth. Finally, these results show that proteomic analysis is a valuable method for identifying potential markers or therapeutic targets related to cancer growth. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11120605     DOI: 10.1006/excr.2000.5066

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Identification of differentially expressed proteins between human esophageal immortalized and carcinomatous cell lines by two-dimensional electrophoresis and MALDI-TOF-mass spectrometry.

Authors:  Xing-Dong Xiong; Li-Yan Xu; Zhong-Ying Shen; Wei-Jia Cai; Jian-Min Luo; Ya-Li Han; En-Min Li
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

Review 2.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

Review 3.  The application of 2D gel-based proteomics methods to the study of breast cancer.

Authors:  Robert C Stein; Marketa J Zvelebil
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

4.  The molecular and biological analysis of ixodid ticks histamine release factors.

Authors:  Albert Mulenga; Abdu F Azad
Journal:  Exp Appl Acarol       Date:  2005       Impact factor: 2.132

5.  Expression of inducible Hsp70 enhances the proliferation of MCF-7 breast cancer cells and protects against the cytotoxic effects of hyperthermia.

Authors:  J A Barnes; D J Dix; B W Collins; C Luft; J W Allen
Journal:  Cell Stress Chaperones       Date:  2001-10       Impact factor: 3.667

6.  Upregulation of TCTP expression in human skin squamous cell carcinoma increases tumor cell viability through anti-apoptotic action of the protein.

Authors:  DI Wu; Ze Guo; Wei Min; Bingrong Zhou; Mingna Li; Wei Li; Dan Luo
Journal:  Exp Ther Med       Date:  2011-12-28       Impact factor: 2.447

Review 7.  Functional proteomics of breast cancer for signal pathway profiling and target discovery.

Authors:  Hubert Hondermarck; Laurent Dollé; Ikram El Yazidi-Belkoura; Anne-Sophie Vercoutter-Edouart; Eric Adriaenssens; Jérôme Lemoine
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

Review 8.  Proteomics in studies of signal transduction in epithelial cells.

Authors:  Serhiy Souchelnytskyi
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

9.  Molecular cloning and expression characterization of translationally controlled tumor protein in silkworm pupae.

Authors:  Zuoming Nie; Zhengbing Lv; Jiawei Qian; Jian Chen; Shanshan Li; Qing Sheng; Dan Wang; Hongdan Shen; Wei Yu; Xiangfu Wu; Yaozhou Zhang
Journal:  Mol Biol Rep       Date:  2009-09-15       Impact factor: 2.316

10.  Potential role of histamine releasing factor (HRF) as a therapeutic target for treating asthma and allergy.

Authors:  Susan M Macdonald
Journal:  J Asthma Allergy       Date:  2012-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.